{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:35:44Z","timestamp":1787063744273,"version":"build-2736575974"},"reference-count":42,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Naomi Hoshino Memorial Research Fund","award":["None"],"award-info":[{"award-number":["None"]}]},{"name":"Sato Pharmaceutical Research Grant","award":["None"],"award-info":[{"award-number":["None"]}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K07035"],"award-info":[{"award-number":["20K07035"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In the treatment of breakpoint cluster region-Abelson (BCR-ABL)-positive chronic myeloid leukemia (CML) using BCR-ABL inhibitors, the appearance of a gatekeeper mutation (T315I) in BCR-ABL is a serious issue. Therefore, the development of novel drugs that overcome acquired resistance to BCR-ABL inhibitors by CML cells is required. We previously demonstrated that a bis-pyridinium fullerene derivative (BPF) induced apoptosis in human chronic myeloid leukemia (CML)-derived K562 cells partially through the generation of reactive oxygen species (ROS). We herein show that BPF enhanced the activation of the mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase (MEK-ERK) pathway in a ROS-independent manner. BPF-induced apoptosis was attenuated by trametinib, suggesting the functional involvement of the MEK-ERK pathway in apoptosis in K562 cells. In addition, the constitutive activation of the MEK-ERK pathway by the enforced expression of the BRAFV600E mutant significantly increased the sensitivity of K562 cells to BPF. These results confirmed for the first time that BPF induces apoptosis in K562 cells through dual pathways\u2014ROS production and the activation of the MEK-ERK pathway. Furthermore, BPF induced cell death in transformed Ba\/F3 cells expressing not only BCR-ABL but also T315I mutant through the activation of the MEK-ERK pathway. These results indicate that BPF is as an effective CML drug that overcomes resistance to BCR-ABL inhibitors.<\/jats:p>","DOI":"10.3390\/ijms23020749","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T14:05:07Z","timestamp":1641909907000},"page":"749","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6528-9162","authenticated-orcid":false,"given":"Kazuya","family":"Sumi","sequence":"first","affiliation":[{"name":"Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tago","sequence":"additional","affiliation":[{"name":"Division of Structural Biochemistry, Department of Biochemistry, Jichi Medical University, Shimotsuke 321-0498, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2226-1944","authenticated-orcid":false,"given":"Yosuke","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0931-1708","authenticated-orcid":false,"given":"Tomoyuki","family":"Ohe","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahiko","family":"Mashino","sequence":"additional","affiliation":[{"name":"Division of Pharmaceutical Sciences, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Funakoshi-Tago","sequence":"additional","affiliation":[{"name":"Division of Hygienic Chemistry, Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11912-008-0057-0","article-title":"Modern approaches to treating chronic myelogenous leukemia","volume":"10","author":"Bello","year":"2008","journal-title":"Curr. Oncol. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0950-3536(97)80003-0","article-title":"BCR-ABL gene variants","volume":"10","author":"Melo","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"ref_3","first-page":"35","article-title":"The Philadelphia chromosome in leukemogenesis","volume":"27","author":"Kang","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/107327480901600202","article-title":"Signaling networks associated with BCR-ABL-dependent transformation","volume":"16","author":"Hazlehurst","year":"2009","journal-title":"Cancer Control."},{"key":"ref_5","first-page":"247","article-title":"Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia","volume":"13","author":"Shuai","year":"1996","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1084\/jem.189.8.1229","article-title":"Signal transducer and activator of transcription (STAT)5 activation by BCR\/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR\/ABL and is required for leukemogenesis","volume":"189","author":"Wasik","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway","volume":"13","author":"Puil","year":"1994","journal-title":"EMBO J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-06-4312","article-title":"BCR-tyrosine 177 plays an essential role in RAS and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia","volume":"67","author":"Chu","year":"2007","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0092-8674(95)90277-5","article-title":"Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene","volume":"82","author":"Goga","year":"1995","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/1078-0432.CCR-09-3314","article-title":"Targeting the BCR-ABL signaling pathway in therapy-resistant Philadelphia chromosome-positive leukemia","volume":"17","author":"Deininger","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1182\/blood-2007-03-080838","article-title":"Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors","volume":"110","author":"Cortes","year":"2007","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Gorre","year":"2001","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of autoinhibition and STI-571\/imatinib resistance revealed by mutagenesis of BCR-ABL","volume":"112","author":"Azam","year":"2003","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3109\/10715760903273849","article-title":"Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells","volume":"43","author":"Nishizawa","year":"2009","journal-title":"Free Radic. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.cellsig.2012.06.014","article-title":"Fullerene derivative prevents cellular transformation induced by JAK2 V617F mutant through inhibiting c-Jun N-terminal kinase pathway","volume":"24","author":"Nagata","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.intimp.2014.02.035","article-title":"Effect of chemical modification on the ability of pyrrolidinium fullerene to induce apoptosis of cells transformed by JAK2 V617F mutant","volume":"20","author":"Tsukada","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.2147\/IJN.S212045","article-title":"Synthesis and antitumor activity of novel pyridinium fullerene derivatives","volume":"14","author":"Yasuno","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"174714","DOI":"10.1016\/j.ejphar.2021.174714","article-title":"A bis-pyridinium fullerene derivative induces apoptosis through the generation of ROS in BCR-ABL-positive leukemia cells","volume":"916","author":"Sumi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2174\/1381612023393125","article-title":"Design and discovery of small molecules targeting raf-1 kinase","volume":"8","author":"Lowinger","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/1078-0432.CCR-10-2200","article-title":"GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition","volume":"17","author":"Gilmartin","year":"2011","journal-title":"Clin. Cancer. Res."},{"key":"ref_23","first-page":"347","article-title":"Edaravone Mitsubishi-Tokyo","volume":"1","author":"Tabrizchi","year":"2000","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrc3760","article-title":"Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond","volume":"14","author":"Holderfield","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0006-291X(02)00445-X","article-title":"Cellular localisation of a water-soluble fullerene derivative","volume":"294","author":"Foley","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1600-0625.2007.00545.x","article-title":"Carboxyfullerenes localize within mitochondria and prevent the UVB-induced intrinsic apoptotic pathway","volume":"16","author":"Chirico","year":"2007","journal-title":"Exp. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12363","DOI":"10.1021\/ja9823969","article-title":"\u2022OH and O2\u2022\u2212 generation in aqueous C60 and C70 solutions by photoirradiation:\u2009 An EPR study","volume":"120","author":"Yamakoshi","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.etap.2014.11.013","article-title":"Macrophage apoptosis induced by aqueous C60 aggregates changing the mitochondrial membrane potential","volume":"39","author":"Zhang","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.04.041","article-title":"Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene","volume":"568","author":"Harhaji","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9269","DOI":"10.1016\/j.biomaterials.2014.07.030","article-title":"The role of low levels of fullerene C60 nanocrystals on enhanced learning and memory of rats through persistent CaMKII activation","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"23512","DOI":"10.1074\/jbc.271.38.23512","article-title":"Protein kinase C activates the MEK-ERK pathway in a manner independent of RAS and dependent on Raf","volume":"271","author":"Ueda","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1541-7786.MCR-19-1120","article-title":"Targeting Opsin4\/melanopsin with a novel small molecule suppresses PKC\/RAF\/MEK\/ERK signaling and inhibits lung adenocarcinoma progression","volume":"18","author":"Wang","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sugiura, R., Satoh, R., and Takasaki, T. (2021). ERK: A double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic Strategy for cancer. Cells, 10.","DOI":"10.3390\/cells10102509"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1242\/jcs.02470","article-title":"MAP kinase pathways","volume":"118","author":"Qi","year":"2005","journal-title":"J. Cell Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bbamcr.2006.11.010","article-title":"ERK implication in cell cycle regulation","volume":"1773","author":"Chambard","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2009.07366.x","article-title":"ERK and cell death: Mechanisms of ERK-induced cell death\u2014Apoptosis, autophagy and senescence","volume":"277","author":"Cagnol","year":"2010","journal-title":"FEBS J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.1073\/pnas.2134254100","article-title":"Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation","volume":"100","author":"Yao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2443.2003.00680.x","article-title":"Essential role for ERK2 mitogen-activated protein kinase in placental development","volume":"8","author":"Hatano","year":"2003","journal-title":"Genes Cells"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1523\/JNEUROSCI.0117-07.2007","article-title":"Extracellular signal-regulated kinase 2 (ERK2) knockdown mice show deficits in long-term memory; ERK2 has a specific function in learning and memory","volume":"27","author":"Satoh","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1523\/JNEUROSCI.2349-11.2011","article-title":"ERK2 contributes to the control of social behaviors in mice","volume":"31","author":"Satoh","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2018.05.018","article-title":"Taxodione induces apoptosis in BCR-ABL-positive cells through ROS generation","volume":"154","author":"Uchihara","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"19588","DOI":"10.1038\/s41598-020-76445-z","article-title":"Coffee decoction enhances tamoxifen proapoptotic activity on MCF-7 cells","volume":"10","author":"Tago","year":"2020","journal-title":"Sci. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/749\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:27:09Z","timestamp":1760362029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23020749"],"URL":"https:\/\/doi.org\/10.3390\/ijms23020749","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]}}}